SAN FRANCISCO, Feb. 21, 2017 -- World-renowned brain scientist Dr. Michael Merzenich will deliver a keynote address at the “I Can Change My Brain” conference at Deakin University in Melbourne, Australia on Sunday, February 26, 2017. Dr. Merzenich is Chief Scientific Officer at Posit Science and Professor Emeritus at University of California San Francisco (UCSF).
Dr. Merzenich will speak on how breakthroughs in brain plasticity in his lab (and in the labs of colleagues across the globe) have now entered the final stage of translational research – resulting in strategies and products that people can engage with today to monitor and improve brain performance and brain health.
Three decades ago, Dr. Merzenich forever changed the way scientists look at the brain with his seminal experiments showing that the adult brain remains plastic – capable of changing chemically, physically and functionally, throughout life, based on sensory and other inputs. Previously, scientists believed that the brain was plastic only in childhood.
Dr. Merzenich realized that plasticity could be harnessed to create tools to benefit humanity. He first applied plasticity in the co-invention of the cochlear implant, which has restored hearing to hundreds of thousands of people living with deafness.
With the wide adoption of personal computers and, then, mobile devices, Dr. Merzenich focused on how to create online (and in app) assessments and exercises that continuously adapt and personalize to monitor and improve individual health and performance.
The exercises in the BrainHQ brain-training platform from Posit Science have been shown to improve performance across a wide range of populations in more than 140 peer-reviewed journal articles.
Studies in healthy mature adults have shown gains in standard and real world measures of cognition (e.g., brain speed, attention, memory and executive function); quality of life (mood, confidence, self-rated health, functional independence); and everyday activities (balance, movement, driving).
Last year, Dr. Merzenich was awarded the Kavli Prize, the highest honor in neuroscience. The prior year, he was awarded the Russ Prize, the highest honor in bio-engineering. He has been elected by his peers to both the National Academy of Sciences and to the National Academy of Medicine in the USA. He also is a member of the Norwegian Academy of Sciences and Letters.
Dr. Merzenich frequently appears on television and in the press. He may be best known to Australian audiences for his role in the award-winning television series “Redesign My Brain.”
Dr. Merzenich is the author of several books, including Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life.
More information about the conference can be found at http://changemybrain.businessbrainmapping.com.
For more information about Dr. Merzenich, contact [email protected]


Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



